{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:07:22Z","timestamp":1790262442040,"version":"4.1.0"},"reference-count":25,"publisher":"Society of Nuclear Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2026,9,1]]},"DOI":"10.2967\/jnumed.126.273055","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:30:26Z","timestamp":1790260226000},"page":"jnumed.126.273055","source":"Crossref","is-referenced-by-count":0,"title":["Association of\n                    <i>ATM<\/i>\n                    Alterations with Outcomes After\n                    <sup>177<\/sup>\n                    Lu-PSMA-617 Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer"],"prefix":"10.2967","author":[{"given":"Vikrant","family":"Mahajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily","family":"Kollitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Boytim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A.","family":"Zorko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian J.","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzan","family":"Cayci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Dehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali T.","family":"Arafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel S.","family":"Antonarakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"2026092407301925000_jnumed.126.273055v1.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107322"},{"key":"2026092407301925000_jnumed.126.273055v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.06.030"},{"key":"2026092407301925000_jnumed.126.273055v1.3","doi-asserted-by":"crossref","first-page":"102764","DOI":"10.1016\/j.xcrm.2026.102764","article-title":"Plasma extracellular vesicle proteomics nominates candidate biomarkers of 177Lu-PSMA-617 outcomes in metastatic prostate cancer patients","volume":"7","author":"Arafa","year":"2026","journal-title":"Cell Rep Med."},{"key":"2026092407301925000_jnumed.126.273055v1.4","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.265952"},{"key":"2026092407301925000_jnumed.126.273055v1.5","doi-asserted-by":"crossref","first-page":"e2300634","DOI":"10.1200\/PO.23.00634","article-title":"Genomic correlates of prostate-specific membrane antigen expression and response to 177Lu-PSMA-617: a retrospective multicenter cohort study","volume":"8","author":"Raychaudhuri","year":"2024","journal-title":"JCO Precis Oncol."},{"key":"2026092407301925000_jnumed.126.273055v1.6","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1038\/s41591-025-03704-9","article-title":"Lutetium-177-PSMA-617 or cabazitaxel in metastatic prostate cancer: circulating tumor DNA analysis of the randomized phase 2 TheraP trial","volume":"31","author":"Kwan","year":"2025","journal-title":"Nat Med."},{"key":"2026092407301925000_jnumed.126.273055v1.7","doi-asserted-by":"crossref","first-page":"oyaf358","DOI":"10.1093\/oncolo\/oyaf358","article-title":"Genomic alterations and associated outcomes in patients with PSMA-positive metastatic castration-resistant prostate cancer treated with 177Lu-PSMA-617","volume":"30","author":"Panian","year":"2025","journal-title":"Oncologist."},{"key":"2026092407301925000_jnumed.126.273055v1.8","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/s41416-021-01508-5","article-title":"Circulating androgen receptor gene amplification and resistance to 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: results of a phase 2 trial","volume":"125","author":"De Giorgi","year":"2021","journal-title":"Br J Cancer."},{"key":"2026092407301925000_jnumed.126.273055v1.9","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1158\/1078-0432.CCR-22-3394","article-title":"Metastatic prostate cancers with BRCA2 versus ATM mutations exhibit divergent molecular features and clinical outcomes","volume":"29","author":"Hwang","year":"2023","journal-title":"Clin Cancer Res."},{"key":"2026092407301925000_jnumed.126.273055v1.10","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1158\/1078-0432.CCR-24-2058","article-title":"Germline-somatic interactions in BRCA-associated cancers: unique molecular profiles and clinical outcomes linking ATM to TP53 synthetic essentiality","volume":"31","author":"Arafa","year":"2025","journal-title":"Clin Cancer Res."},{"key":"2026092407301925000_jnumed.126.273055v1.11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41571-020-0395-x","article-title":"Olaparib for DNA repair-deficient prostate cancer - one for all, or all for one?","volume":"17","author":"Antonarakis","year":"2020","journal-title":"Nat Rev Clin Oncol."},{"key":"2026092407301925000_jnumed.126.273055v1.12","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30"},{"key":"2026092407301925000_jnumed.126.273055v1.13","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-23-0467"},{"key":"2026092407301925000_jnumed.126.273055v1.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2017.05.015"},{"key":"2026092407301925000_jnumed.126.273055v1.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.11.033"},{"key":"2026092407301925000_jnumed.126.273055v1.16","doi-asserted-by":"publisher","DOI":"10.1002\/pros.24454"},{"key":"2026092407301925000_jnumed.126.273055v1.17","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.eururo.2018.01.035","article-title":"Germline DNA-repair gene mutations and outcomes in men with metastatic castration-resistant prostate cancer receiving first-line abiraterone and enzalutamide","volume":"74","author":"Antonarakis","year":"2018","journal-title":"Eur Urol."},{"key":"2026092407301925000_jnumed.126.273055v1.18","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1002\/cncr.33487","article-title":"Differential treatment outcomes in BRCA1\/2-, CDK12-, and ATM-mutated metastatic castration-resistant prostate cancer","volume":"127","author":"Kwon","year":"2021","journal-title":"Cancer."},{"key":"2026092407301925000_jnumed.126.273055v1.19","doi-asserted-by":"publisher","DOI":"10.1038\/258427a0"},{"key":"2026092407301925000_jnumed.126.273055v1.20","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djaa095"},{"key":"2026092407301925000_jnumed.126.273055v1.21","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.eururo.2018.09.040","article-title":"Efficacy of radium-223 in bone-metastatic castration-resistant prostate cancer with and without homologous repair gene defects","volume":"76","author":"Isaacsson Velho","year":"2019","journal-title":"Eur Urol."},{"key":"2026092407301925000_jnumed.126.273055v1.22","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-017-0027-4"},{"key":"2026092407301925000_jnumed.126.273055v1.23","doi-asserted-by":"crossref","first-page":"10648","DOI":"10.1038\/s41467-024-54847-1","article-title":"AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patients","volume":"15","author":"Knutson","year":"2024","journal-title":"Nat Commun."},{"key":"2026092407301925000_jnumed.126.273055v1.24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1315815"},{"key":"2026092407301925000_jnumed.126.273055v1.25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamaoncol.2021.2350","article-title":"Concordance of DNA repair gene mutations in paired primary prostate cancer samples and metastatic tissue or cell-free DNA","volume":"7","author":"Schweizer","year":"2021","journal-title":"JAMA Oncol."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.126.273055","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:30:27Z","timestamp":1790260227000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.126.273055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":25,"alternative-id":["10.2967\/jnumed.126.273055"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.126.273055","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]}}}